Home Podcasts To Immunity and Beyond
To Immunity and Beyond

To Immunity and Beyond

Oxford University 16 Episodes Jun 18, 2026

A series produced by the Oxford Immunology Network, where Professor Paul Klenerman discusses recent groundbreaking publications with colleagues. They explore original scientific goals, challenges encountered, and future ambitions in immunology. The podcast is aimed at students and professionals in immunology, medical sciences, and biology.

Episodes

CellTypeAI: Automated cell identification for scRNA-seq using local generative-AI Jun 18, 2026 1274 A conversation with Dr Rufus Daw about CellTypeAI. As single-cell datasets grow from thousands to hundreds of thousands of cells, accurate cell annotation is becoming a major bottleneck in biomedical research. In this episode, bioinformatician Rufus Daw discusses CellTypeAI, a new locally deployable AI framework that uses large language models to automate cell-type identification from single-cell
The MRC Centre of Research Excellence in Exposome Immunology Apr 27, 2026 1502 A conversation with Professor Sheena Cruickshank about the new MRC Centre of Research Excellence in Exposome Immunology. To mark World Immunology Day, we’re joined by Professor Sheena Cruickshank from the MRC Centre of Research Excellence in Exposome Immunology. Sheena and Paul discuss how environmental and lifestyle exposures, from pollution to microbiome and socioeconomic factors, shape immune r
Unravelling T-Cell Recognition – Insights from Immunology and AI Feb 4, 2026 2498 A conversation with Professor Hashem Koohy about possibilities for use of AI in driving forward T cell research. In the first To Immunity and Beyond episode of 2026, Paul Klenerman speaks with systems biologist Hashem Koohy, whose career journey from pure mathematics to immunology offers a fresh lens on T cell research. Hashem describes how advances in genomics, data science, and AI led him to fo
HIV in 2025 - the latest science, global burden and future outlook Feb 4, 2026 2259 A conversation with Professor Andrew McMichael, Professor Tomáš Hanke, and Dr Fon Acho about current priorities in HIV treatment and prevention. In this episode of To Immunity and Beyond, we talk to HIV immunologist Professor Andrew McMichael, vaccinologist Professor Tomáš Hanke, and Dr Fon Acho, a Cameroonian doctor and Oxford MSc immunology graduate. We discuss the global burden of HIV, and the
Sustained aviremia despite anti-retroviral therapy non-adherence in male children after in utero HIV transmission Nov 27, 2025 2245 A conversation with Philip Goulder about the recent article ‘Sustained aviremia despite anti-retroviral therapy non-adherence in male children after in utero HIV transmission’. In this episode of To Immunity and Beyond, we discuss a prospective study of 284 children from KwaZulu-Natal, South Africa, who were treated very early with antiretroviral therapy (ART) after mother-to-child transmission of
Regulatory T cell therapy is associated with distinct immune regulatory lymphocytic infiltrates in kidney transplants Oct 20, 2025 1534 A conversation with Fadi Issa about his recent article on regulatory T cell therapy in kidney transplants. In this episode of To Immunity and Beyond, Paul Klenerman talks with surgeon and immunologist Fadi Issa about pioneering regulatory T-cell therapy in kidney transplantation. Fadi shares his journey from reconstructive surgery to immune tolerance research and discusses the groundbreaking, fir
Ebola virus persistence: implications for human-to-human transmission and new outbreaks Sep 11, 2025 1328 A conversation with Miles Carroll and Oliver Meek about their recent Ebola virus persistence review article. In this episode, Oliver Meek and Miles Carroll discuss their recent review on Ebola virus (EBOV) persistence, set against the broader context of the West African epidemic. They share insights into how viral reservoirs form in immune-privileged sites and the immunological signatures linked t
‘Dangerous Matter’: A New Opera on Vaccine Science, Memory, and Innovation Jun 23, 2025 1925 A conversation with Zakiya Leeming and Rachel Hindmarsh about the Thanks for the Memories project and a new opera. The Thanks for the Memories public engagement programme is about to premier a new opera, ‘Dangerous Matter’, at the Royal Northern College of Music on June 24th, 2025, inspired both by the story of Lady Mary Wortley Montagu, and by research into immune memory. On this episode we talk
CMV serostatus is associated with improved survival and delayed toxicity onset following anti-PD-1 checkpoint blockade Jun 13, 2025 2098 A conversation with Ben Fairfax about the recent article: CMV serostatus is associated with improved survival and delayed toxicity onset following anti-PD-1 checkpoint blockade. This episode discusses Milotay, G., Little, M., Watson, R.A. et al. CMV serostatus is associated with improved survival and delayed toxicity onset following anti-PD-1 checkpoint blockade. Nat Med (2025). https://doi.org/10
Self-interactive learning: Fusion and evolution of multi-scale histomorphology features for molecular traits prediction in computational pathology May 22, 2025 1450 A conversation with Yang Hu about his recent article: Self-interactive learning: Fusion and evolution of multi-scale histomorphology features for molecular traits prediction in computational pathology. This episode discusses Yang Hu et al, ‘Self-interactive learning: Fusion and evolution of multi-scale histomorphology features for molecular traits prediction in computational pathology’, Medical Im
Research with Human Tissue Samples on the International Space Station, with Dr Ghada Alsaleh Apr 29, 2025 1211 Research on human cells in space may uncover the hidden mechanisms behind ageing. Exciting developments are underway at the Space Innovation Lab at the University of Oxford! The launch of human tissue samples to the International Space Station marks a bold and forward-looking step in scientific discovery—one aimed at unravelling the mysteries of ageing. This pioneering research holds tremendous po
Analysis of the diverse antigenic landscape of the malaria protein RH5 identifies a potent vaccine-induced human public antibody clonotype Mar 24, 2025 1657 Dr Kirsty McHugh and Dr Carolyn Nielsen discuss a recent Cell article: ‘Analysis of the diverse antigenic landscape of the malaria protein RH5 identifies a potent vaccine-induced human public antibody clonotype’. This episode discusses the following article: Barrett, J et al., Analysis of the diverse antigenic landscape of the malaria protein RH5 identifies a potent vaccine-induced human public an

Recommended